Drug intelligence / Profile preview

IgY Drink Plus

Development stage: Unknown
Lead developer: ADBiotech
Modality: Antibody-Based Therapeutics
Administration: Oral

Overview

IgY Drink Plus is a veterinary feed additive and food product developed by ADBiotech. It utilizes immunoglobulin Y (IgY) antibodies, which are derived from the egg yolks of immunized hens. These antibodies are designed to provide passive immunity and support the health of livestock and fisheries by targeting specific pathogens in the gastrointestinal tract. The product is marketed as part of ADBiotech's animal health and functional food lines and is not a clinical-stage pharmaceutical drug for human use. It is primarily used to prevent enteric infections and improve overall health in agricultural and aquaculture settings.

Brand names: IgY Drink Plus아이지드링크플러스
Other names: IgY Drink Plus아이지드링크플러스

Beyond the preview

Go deeper on IgY Drink Plus.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on IgY Drink Plus.

Explore the full profile